Mandate

Vinge advises Triton Fund II in connection with the sale of Bravida

May 16, 2012

Vinge has advised Triton Fund II and the minority shareholders in connection with the sale of the Bravida Group, the leading group in Scandinavia within technical installations and services for real estate to Bain Capital.  Triton has owned Bravida, which has approximately 8 000 employees and a turnover last year of SEK 10.8 billion, since 2006.

Vinge’s team was led by responsible partner, Christina Kokko and also consisted of partners Peter Bäärnhielm and Charlotte Levin, associates Paul Dali, Jo-Anna Nordström, Nicolina Kindblom, Rikard Lindahl, Louise Brorsson Salomon, Albert Wållgren and several lawyers from Vinge’s specialist practice groups and project assistant Ida Norlin.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026